Academic Small Molecule Drug Discovery Using AstraZeneca's Screening Facilities

This funding opportunity enables academic researchers to advance drug discovery by accessing AstraZeneca's extensive compound library (over 2 million molecules) and cutting-edge high-throughput screening facilities. The Medical Research Council supports up to four projects annually, with individual grants available up to £270,000. The program is designed to accelerate the identification of potential starting points for small molecule medicinal drugs through strategic academic-industry partnerships. Eligible researchers can leverage world-class screening infrastructure and pharmaceutical expertise to progress early-stage drug development while maintaining collaborative relationships with AstraZeneca scientists.